Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

National Healthcare (NHC) Other Operating Expenses (2016 - 2025)

National Healthcare's Other Operating Expenses history spans 16 years, with the latest figure at $341.2 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 444.23% year-over-year to $341.2 million; the TTM value through Dec 2025 reached $1.3 billion, up 178.09%, while the annual FY2023 figure was $6.2 million, N/A changed from the prior year.
  • Other Operating Expenses reached $341.2 million in Q4 2025 per NHC's latest filing, roughly flat from $340.9 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $341.2 million in Q4 2025 to a low of -$99.1 million in Q4 2024.
  • Average Other Operating Expenses over 5 years is $176.7 million, with a median of $252.1 million recorded in 2022.
  • Peak YoY movement for Other Operating Expenses: surged 7760.42% in 2022, then tumbled 256.11% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at -$29.0 million in 2021, then soared by 945.79% to $245.3 million in 2022, then tumbled by 111.35% to -$27.8 million in 2023, then crashed by 256.11% to -$99.1 million in 2024, then soared by 444.23% to $341.2 million in 2025.
  • Per Business Quant, the three most recent readings for NHC's Other Operating Expenses are $341.2 million (Q4 2025), $340.9 million (Q3 2025), and $329.5 million (Q2 2025).